<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01482026</url>
  </required_header>
  <id_info>
    <org_study_id>2011.682/25</org_study_id>
    <nct_id>NCT01482026</nct_id>
  </id_info>
  <brief_title>Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale and Epilepsy</brief_title>
  <official_title>Sensitivity of ADHD-IV Rating Scale in the Evaluation of the Evolution of Attention Disorders Associated With Childhood Epilepsy : a Validation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The cognitive and psychiatric comorbidities are crucial endpoints in epileptic patients.
      Among these comorbidities, the Attention-Deficit Hyperactivity Disorder (ADHD) accounts for
      one of the most important in terms of frequency and psychosocial and educational
      consequences.

      In these conditions, our study was designed to estimate the sensitivity to changes of the
      different sub-scores of the ADHD rating Scale IV (ADHD RS IV) in epileptic patient. This will
      then optimize our methodological approach for a therapeutic trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of the ADHD rating scale IV inattention subscore</measure>
    <time_frame>Change from baseline in ADHD rating scale IV inattention subscore at 12 to16 weeks</time_frame>
    <description>Evolution of the ADHD rating scale IV inattention subscore in treated versus non treated patients, after 12 to 16 weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evolution of the ADHD rating scale IV global score</measure>
    <time_frame>Change from baseline in ADHD rating scale IV global score at 12 to16 weeks</time_frame>
    <description>Evolution of the ADHD rating scale IV global score in treated versus non treated patients, after 12 to 16 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of the ADHD rating scale IV hyperactivity subscore</measure>
    <time_frame>Change from baseline in ADHD rating scale IV hyperactivity subscore at 12 to16 weeks</time_frame>
    <description>Evolution of the ADHD rating scale IV hyperactivity subscore in treated versus non treated patients, after 12 to 16 weeks.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">173</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>Treated patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients for whom ADHD treatment is introduced at enrolment. Evolution of the ADHD Rating Scale-IV inattention subscore</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non treated patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients for whom no ADHD treatment is required at enrolment. Evolution of the ADHD Rating Scale-IV inattention subscore</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ADHD Rating Scale-IV</intervention_name>
    <description>ADHD Rating Scale-IV test</description>
    <arm_group_label>Treated patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ADHD Rating Scale-IV</intervention_name>
    <description>ADHD Rating Scale-IV test</description>
    <arm_group_label>Non treated patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children aged 6 to 15 years and 11 months;

          -  male or female;

          -  with a diagnosis of ADHD : predominantly inattentive or combined hyperactive-impulsive
             and inattentive according to the DSM IV criteria;

          -  children who agreed to participate to the protocol and whose legal representatives
             have clearly expressed their non-opposition to participate.

        Exclusion Criteria:

          -  Patients below 6 years old or patients older than 16 years;

          -  with a diagnosis of ADHD predominantly hyperactive-impulsive subtype ADHD according to
             the DSM IV criteria;

          -  mental retardation defined by a score &lt; 70 at the verbal comprehension index and the
             perceptual reasoning score of the Wechsler Intelligence Scale for Children - Fourth
             Edition (WISC-IV)

          -  established diagnosis of any psychiatric co-morbidity other than ADHD according to the
             DSM IV criteria (pervasive developmental disorders including autism, bipolar disorder,
             psychotic disorder).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sylvain RHEIMS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Neurologie Fonctionnelle et Epileptologie, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Neurologie pédiatrique, CHU d'Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie Pédiatrique, CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <zip>49033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie pédiatrique, CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unité de Neurologie de l'Enfant et de l'Adolescent, Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut des Epilepsies de l'Enfant et de l'Adolescent, Hôpital Femme Mère Enfant</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie Fonctionnelle et Epileptologie, Hôpital Neurologique Pierre Wertheimer</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service d'épileptologie pédiatrique, CHR de Chambéry</name>
      <address>
        <city>Chambéry</city>
        <zip>73011</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr ISNARD</name>
      <address>
        <city>Lyon</city>
        <zip>69002</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie pédiatrique, Hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie Pédiatrique, Hôpital Robert-Debré</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie pédiatrique, Hôpital Neckert-Enfants malades</name>
      <address>
        <city>Paris</city>
        <zip>75743</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Pédiatrie, Hôpital Sud</name>
      <address>
        <city>Rennes</city>
        <zip>35203</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Référent des Epilepsies Rares, Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie Pédiatrique, Hôpital des Enfants</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie Pédiatrique, CHU de Tours</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2011</study_first_submitted>
  <study_first_submitted_qc>November 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2011</study_first_posted>
  <last_update_submitted>January 20, 2016</last_update_submitted>
  <last_update_submitted_qc>January 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Epilepsy</keyword>
  <keyword>Attention deficit</keyword>
  <keyword>ADHD rating scale IV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

